X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES DIVIS LABORATORIES JUBILANT LIFE SCIENCES/
DIVIS LABORATORIES
 
P/E (TTM) x 19.2 33.6 57.0% View Chart
P/BV x 4.6 5.5 84.8% View Chart
Dividend Yield % 0.4 0.9 43.3%  

Financials

 JUBILANT LIFE SCIENCES   DIVIS LABORATORIES
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
DIVIS LABORATORIES
Mar-17
JUBILANT LIFE SCIENCES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1871,222 15.3%   
Low Rs65784 8.3%   
Sales per share (Unadj.) Rs364.3153.1 238.0%  
Earnings per share (Unadj.) Rs6.839.9 17.1%  
Cash flow per share (Unadj.) Rs24.544.6 54.9%  
Dividends per share (Unadj.) Rs3.0010.00 30.0%  
Dividend yield (eoy) %2.41.0 238.9%  
Book value per share (Unadj.) Rs164.9201.8 81.7%  
Shares outstanding (eoy) m159.28265.47 60.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.36.6 5.3%   
Avg P/E ratio x18.425.1 73.3%  
P/CF ratio (eoy) x5.122.5 22.9%  
Price / Book Value ratio x0.85.0 15.4%  
Dividend payout %43.825.0 175.0%   
Avg Mkt Cap Rs m20,061266,266 7.5%   
No. of employees `0006.29.7 63.5%   
Total wages/salary Rs m11,0524,687 235.8%   
Avg. sales/employee Rs Th9,383.04,175.0 224.7%   
Avg. wages/employee Rs Th1,786.9481.5 371.1%   
Avg. net profit/employee Rs Th176.31,089.3 16.2%   
INCOME DATA
Net Sales Rs m58,03440,643 142.8%  
Other income Rs m191749 25.5%   
Total revenues Rs m58,22441,392 140.7%   
Gross profit Rs m5,78614,460 40.0%  
Depreciation Rs m2,8121,233 228.0%   
Interest Rs m3,23723 14,323.9%   
Profit before tax Rs m-7213,953 -0.5%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6963,349 20.8%   
Profit after tax Rs m1,09010,604 10.3%  
Gross profit margin %10.035.6 28.0%  
Effective tax rate %-965.924.0 -4,024.1%   
Net profit margin %1.926.1 7.2%  
BALANCE SHEET DATA
Current assets Rs m29,28040,105 73.0%   
Current liabilities Rs m38,9126,595 590.1%   
Net working cap to sales %-16.682.5 -20.1%  
Current ratio x0.86.1 12.4%  
Inventory Days Days84119 71.2%  
Debtors Days Days5181 62.8%  
Net fixed assets Rs m55,71219,995 278.6%   
Share capital Rs m155531 29.1%   
"Free" reserves Rs m20,96853,043 39.5%   
Net worth Rs m26,26553,574 49.0%   
Long term debt Rs m17,1690-   
Total assets Rs m88,60661,585 143.9%  
Interest coverage x1.0618.4 0.2%   
Debt to equity ratio x0.70-  
Sales to assets ratio x0.70.7 99.2%   
Return on assets %4.917.3 28.3%  
Return on equity %4.219.8 21.0%  
Return on capital %11.626.1 44.3%  
Exports to sales %37.80-   
Imports to sales %16.525.2 65.3%   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,56710,259 93.3%   
Fx inflow Rs m22,00435,384 62.2%   
Fx outflow Rs m11,74910,399 113.0%   
Net fx Rs m10,25524,985 41.0%   
CASH FLOW
From Operations Rs m8,02611,493 69.8%  
From Investments Rs m-1,744-11,372 15.3%  
From Financial Activity Rs m-4,447-93 4,777.0%  
Net Cashflow Rs m1,83428 6,459.3%  

Share Holding

Indian Promoters % 45.6 52.0 87.7%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 11.8 73.7%  
FIIs % 21.2 19.0 111.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 17.2 122.7%  
Shareholders   23,815 31,796 74.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  IPCA LABS  NATCO PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Cuts Losses; TCS Up 3%(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day but clawed back some gains in the final hours of the trading window.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (4QFY18); Net Profit Up 0.9%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.9% YoY). Sales on the other hand came in at Rs 11 bn (up 2.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 15, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS